Technology companies living under the constant threat of patent litigation are increasingly inking cross-licensing deals and generating a broad mix of patent and transactional work for attorneys.

Attorneys say cross-licenses, which are comprehensive or limited rights to use another company’s patent technology, are particularly favored by biotechnology and information-technology companies as a way to avoid or settle litigation.